• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

What Causes a Cell to Become Cancerous?

Share:

November 6, 2018

Unlike bacteria or viruses, which infect the body from the outside, cancer originates in the body’s own cells. The disease begins deep in the cell nucleus, in the chromosomes that contain our genes.

Of the approximately 22,000 genes in human cells, several hundred are involved in the process of cell division. These genes ensure that division occurs in an orderly, controlled manner—that each step in the process occurs in the right order, at the right time, with the right prompts, and the right pace—and that, after a certain number of divisions, a cell dies.

Sometimes, a gene will acquire an abnormality that interferes with its ability to function. This can take several forms:

  • A mutation, in which the DNA within the gene is misspelled
  • A copying error, in which too many or too few copies of a gene are present
  • A translocation, in which a gene or section of gene gets sewn into the wrong section of the genome.

These errors can occur in a variety of ways. In some cases, they may be inherited from a parent. More often, they arise during one’s life, as a result of exposure to harmful chemicals such as those found in tobacco, exposure to too much ultraviolet light from the sun, or simply bad luck – a mistake made during the process of DNA duplication during cell division.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Most of the time, these non-inherited errors—known as somatic mutations—can be corrected by the cell. Cells have a variety of mechanisms for “proofreading” their DNA, for verifying that the letters of the genetic code are in the proper order and, when they are not, replacing them with the right letters. When the genetic derangements are so extensive that the cell cannot function normally, or that cell division threatens to veer out of control, special genes order that the cell die for the good of the body as a whole.

When these corrections are not made, or when a diseased cell fails to self-destruct, cell growth and division can begin to break free of their constraints. As more mutations occur, affecting more aspects of cell life, a cell may gain the ability to grow without restraint, to invade nearby tissue and drift to other parts of the body, hide from the immune system, and outlive its normal lifespan – to become, in effect, a cancer cell. The process usually occurs over a period of years.

Although these mutations give cancer cells a survival advantage over normal cells, they also create dependency – the cancer cell literally cannot live without them. Targeting such mutations with specially designed drugs remains one of the greatest areas of promise in cancer medicine.

Date: November 6, 2018

Source: Insights From Dana-Farber

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Innovaccer Launches Self-Serve Conversational AI AssistantInnovaccer Launches Self-Serve Conversational AI Assistant
  • A Look at Operational and Clinical Applications of AI in HealthcareA Look at Operational and Clinical Applications of AI in Healthcare
  • Insomnia Drugs Market Industry | Covid-19 – Global Impact and Forecast Report 2020-2025Insomnia Drugs Market Industry | Covid-19 – Global Impact and Forecast Report 2020-2025
  • Voice Assistants Predict Driving Accident Risk in SeniorsVoice Assistants Predict Driving Accident Risk in Seniors
  • With More Than $4.6B in Fundings, Q3 2020 was An Unprecedented Showing from Digital Health InvestorsWith More Than $4.6B in Fundings, Q3 2020 was An Unprecedented Showing from Digital Health Investors
  • Scilex Holding Company, a Sorrento Company, has Entered a Term Sheet to Acquire Ancora Medical Inc.Scilex Holding Company, a Sorrento Company, has Entered a Term Sheet to Acquire Ancora Medical Inc.
  • Apple’s Patent Suggests Health Tracking via Smart ClothesApple’s Patent Suggests Health Tracking via Smart Clothes
  • Pacgen Announces Proposed Acquisition by General Biologicals CorporationPacgen Announces Proposed Acquisition by General Biologicals Corporation

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications